Key takeaways
- • Severity: Moderate — adjust timing or dose.
- • Mounjaro (type 2 diabetes (FDA-approved T2D)) and Prednisone (Deltasone) (Systemic corticosteroid).
- • Clinical management: Increase glucose monitoring during steroid courses. Prescribers may temporarily intensify glucose-lowering therapy (e.g., add insulin) during steroid use in diabetic patients. Defer all decisions to the prescriber.
- • Monitoring: Fingerstick or CGM glucose more frequently during steroid courses, particularly in diabetics. Blood pressure monitoring.
Mechanism
Systemic corticosteroids raise blood glucose through gluconeogenesis and insulin resistance, partially counteracting tirzepatide's glycemic effects. This is most clinically relevant in diabetic patients on tirzepatide, where short courses of prednisone can produce significant hyperglycemia despite GLP-1 therapy. No direct PK interaction.
Clinical management
Increase glucose monitoring during steroid courses. Prescribers may temporarily intensify glucose-lowering therapy (e.g., add insulin) during steroid use in diabetic patients. Defer all decisions to the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Mounjaro or Prednisone (Deltasone).
Monitoring
Fingerstick or CGM glucose more frequently during steroid courses, particularly in diabetics. Blood pressure monitoring.
When to call your doctor
- Hyperglycemia symptoms (excessive thirst, urination, fatigue)
- Glucose readings consistently above 250 mg/dL
- DKA symptoms (nausea, abdominal pain, fruity breath)
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed in current FDA label
Editorial confidence: 7/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Prednisone (Deltasone) with Mounjaro?
Clinically meaningful — typically managed with dose/timing changes. Increase glucose monitoring during steroid courses. Prescribers may temporarily intensify glucose-lowering therapy (e.g., add insulin) during steroid use in diabetic patients. Defer all decisions to the prescriber. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Mounjaro + Prednisone (Deltasone) interaction?
Systemic corticosteroids raise blood glucose through gluconeogenesis and insulin resistance, partially counteracting tirzepatide's glycemic effects. This is most clinically relevant in diabetic patients on tirzepatide, where short courses of prednisone can produce significant hyperglycemia despite GLP-1 therapy. No direct PK interaction.
What should I monitor when on Mounjaro + Prednisone (Deltasone)?
Fingerstick or CGM glucose more frequently during steroid courses, particularly in diabetics. Blood pressure monitoring.
When should I call my doctor?
Contact your prescriber if you notice any of: Hyperglycemia symptoms (excessive thirst, urination, fatigue); Glucose readings consistently above 250 mg/dL; DKA symptoms (nausea, abdominal pain, fruity breath).
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.